...
首页> 外文期刊>Pharmaceutics >The Design of Anionic Surfactant-Based Amino-Functionalized Mesoporous Silica Nanoparticles and their Application in Transdermal Drug Delivery
【24h】

The Design of Anionic Surfactant-Based Amino-Functionalized Mesoporous Silica Nanoparticles and their Application in Transdermal Drug Delivery

机译:基于阴离子表面活性剂的氨基官能化介孔二氧化硅纳米粒子的设计及其在透皮药物递送中的应用

获取原文

摘要

Melanoma remains the most lethal form of skin cancer and most challenging to treat despite advances in the oncology field. Our work describes the utilization of nanotechnology to target melanoma locally in an attempt to provide an advanced and efficient quality of therapy. Amino-functionalized mesoporous silica nanoparticles (MSN-NH 2 ) were developed in situ through the utilization of anionic surfactant and different volumes of 3-aminopropyltriethoxysilane (APTES) as a co-structure directing agent (CSDA). Prepared particles were characterized for their morphology, particles size, 5-flurouracol (5-FU) and dexamethasone (DEX) loading capacity and release, skin penetration, and cytotoxicity in vitro in HT-144 melanoma cells. Results of transmission electron microscopy (TEM) and nitrogen adsorption–desorption isotherm showed that using different volumes of APTES during the functionalization process had an impact on the internal and external morphology of the particles, as well as particle size. However, changing the volume of APTES did not affect the diameter of formed mesochannels, which was about 4 nm. MSN-NH 2 showed a relatively high loading capacity of 5-FU (12.6 ± 5.5) and DEX (44.72 ± 4.21) when using drug: MSN-NH 2 ratios of 5:1 for both drugs. The release profile showed that around 83% of 5-FU and 21% of DEX were released over 48 h in pH 7.4. The skin permeability study revealed that enhancement ratio of 5-Fu and DEX using MSN-NH 2 were 4.67 and 5.68, respectively, relative to their free drugs counterparts. In addition, the accumulation of drugs in skin layers where melanoma cells usually reside were enhanced approximately 10 times with 5-FU and 5 times with DEX when delivering drugs using MSN-NH 2 compared to control. MSN-NH 2 alone was nontoxic to melanoma cells when incubated for 48 h in the range of 0 to 468 μg/mL. The combination of 5-FU MSN-NH 2 and DEX MSN-NH 2 showed significant increase in toxicity compared to their free dug counterparts and exhibited a synergetic effect as well as the ability to circumvent DEX induced 5-FU resistance in melanoma cells.
机译:黑色素瘤仍然是最致命的皮肤癌形式,尽管肿瘤学领域进展,但最挑战治疗。我们的作品描述了纳米技术在本地靶向黑色素瘤的利用,试图提供先进和高效的治疗质量。通过利用阴离子表面活性剂和不同体积的3-氨基丙基三乙氧基硅烷(Aptes)作为共结构指导剂(CSDA)以原位开发氨基官能化的介孔二氧化硅纳米粒子(MSN-NH 2)。在HT-144黑素瘤细胞中,制备的颗粒的形态,颗粒尺寸,5-氟克(5-FU)和地塞米松(DEX)加载能力和释放,皮肤渗透和细胞毒性。透射电子显微镜(TEM)和氮吸附 - 解吸等温度的结果表明,在官能化过程中使用不同体积的脂肪,对颗粒的内部和外部形态以及粒度产生影响。然而,改变容器的体积不会影响形成的Mesochannel的直径,即约4nm。 MSN-NH 2在使用药物时显示出5-FU(12.6±5.5)和DEX(44.72±4.21)的较高负载能力:两种药物的MSN-NH 2比率为5:1。释放型材显示,在pH 7.4中,约83%的5-富和21%的DEX释放超过48小时。皮肤渗透性研究表明,相对于其游离药物对应物,使用MSN-NH 2的5-FU和DEX的增强比例分别为4.67和5.68。此外,皮肤层中药物的积累在黑色素瘤细胞通常在使用MSN-NH 2与对照相比,在使用MSN-NH 2递送药物时,用5-FU和5次增强约10次。当温育48小时的0至468μg/ ml的范围内时,MSN-NH 2单独对黑色素瘤细胞无毒。与其自由挖掘对应物相比,5-FU MSN-NH 2和DEX MSN-NH 2和DEX MSN-NH 2的组合显示出毒性的显着增加,并表现出协同效应以及规避耐候诱导的黑色素瘤细胞5-FU抗性的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号